RxAnte is a leading predictive analytics and clinical services company dedicated to improving medication use and health outcomes. By providing health plans and providers with actionable insights, strategies, and a portfolio of interventions, RxAnte helps make medications work better for everyone.
Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, the RxAnte portfolio of solutions includes patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, a web-based work flow solution, and an award-winning call center to provide clients with the insights they need and results they want in improving medication use.
Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, the RxAnte portfolio of solutions includes patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, a web-based work flow solution, and an award-winning call center to provide clients with the insights they need and results they want in improving medication use.
Location: United States
Employees: 51-200
Total raised: $25M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | Trinity Ca... | trinitycap... |
| 29.01.2026 | PNC Erievi... | pnc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2022 | - | $25M | - |
Mentions in press and media 13
| Date | Title | Description |
| 14.01.2026 | RxAnte Announces Strategic Growth Investment From Primus Capital | RxAnte, a provider of analytics, software, and clinical services for pharmacy care management, announced it has secured a strategic growth investment from Primus Capital as it looks to scale its value-based pharmacy programs and expand clin... |
| 13.01.2026 | RxAnte Raises Strategic Growth Funding | RxAnte, a Portland, Maine-based provider of analytics, software, and services for pharmacy care management, raised a strategic growth investment of undisclosed amount. The round was led by Primus Capital, with continued support from long-te... |
| 21.12.2022 | RxAnte Receives $25M Growth Financing | RxAnte, a Washington, D.C-based pharmacy care management business company, received $25M in Growth financing. Trinity Capital Inc. (NASDAQ: TRIN, TRINL), provided the facility. $15M was drawn under the facility, and RxAnte has the option to... |
| 25.08.2017 | Medication Adherence Tech: A dynamic and crowded market, but where are the winners in the space? (Part 1 of 2) | About the Authors: @DanGebremedhin is a Principal at Flare Capital Partners, an early stage Health Technology and Services focused VC Firm. He is a practicing physician at the Massachusetts General Hospital, previously served as a Medical D... |
| 03.02.2015 | West Health CEO on what kinds of healthcare cost-lowering startups he’s after | Valeriani says West Health’s more mission-driven than typical venture capital firms – that “the calculus to evaluate the effectiveness of our fund isn’t solely financial.” Returns are fed back into the West Health endowment, which funds the... |
| 31.01.2014 | Educated guesstimates about the Audax Health price tag start at $100M and rise to $400M+ | Setting aside the company’s web-based platform, Audax’s high-powered board probably didn’t hurt in getting the company to this point either. Its chairman is Richard Klaussner, who helped set up the Bill & Melinda Gates Foundation’s glob... |
| 28.09.2012 | Can data analysis predict who will adhere to medications, which interventions would help? | The startup isn’t trying to create interventions for medication adherence; rather, it’s trying to help clinicians, payers and pharmaceutical companies know which patients will be non-compliant, and which interventions would be most likely t... |
| 12.09.2012 | RxAnte Raises Series A Financing | RxAnte, Inc., a McLean, VA-based health care improvement company providing a new and innovative approach for improving medication adherence, has raised a Series A financing. The round – whose amount was not disclosed – was led by Aberdare V... |
| 12.09.2012 | RxAnte Closes Series A Financing | MCLEAN, VA, Health care improvement company providing a new and innovative approach for improving medication adherence, announced today that it has raised a Series A financing led by Aberdare Ventures. >> Click here for more fundin... |
| - | RxAnte | “RxAnte is the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs.” |
Show more